Story perspectives

U.S. Political Pressure Threatens mRNA Vaccine Progress

1/1/2026

Summary

Story summary

Messenger RNA (mRNA) vaccines have shown efficacy against Covid, but prospects are uncertain due to U.S. political pressure.
U.S. President Donald Trump has pursued an anti-mRNA stance, led by Health Secretary Robert F. Kennedy Jr., cutting funding.
United Kingdom positions itself as a leader in mRNA research and manufacturing, focusing on cancer therapies.
Some researchers consider relocating to Europe, which aims to expand its mRNA capabilities amid U.S. policy shifts.

1 of 1

Story summary

Messenger RNA (mRNA) vaccines have shown efficacy against Covid, but prospects are uncertain due to U.S. political pressure.
U.S. President Donald Trump has pursued an anti-mRNA stance, led by Health Secretary Robert F. Kennedy Jr., cutting funding.
United Kingdom positions itself as a leader in mRNA research and manufacturing, focusing on cancer therapies.
Some researchers consider relocating to Europe, which aims to expand its mRNA capabilities amid U.S. policy shifts.